The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is proud to denote nan motorboat of nan Global Radiopharmaceutical Trial Finder a revolutionary, AI-powered level designed to thief researchers, clinicians and patients instantly observe radiopharmaceutical objective tests that meet their circumstantial needs. This inaugural represents a actual measurement toward SNMMI s extremity of ensuring diligent entree to life-changing atomic medicine procedures.
Developed by Ancora.ai and hosted connected nan SNMMI website, nan Trial Finder is designed to destruct barriers to objective proceedings information by offering a streamlined, user-friendly acquisition for physicians, patients, and researchers. The level utilizes real-time world tests information refreshed each 24 hours from ClinicalTrials.gov and 3 further world registries. No individual accusation is stored aliases sold.
Clinical tests are basal to nan improvement of caller radiopharmaceuticals, which person nan imaginable to diagnose, treat, and successful immoderate cases cure crab and different diseases. According to information from nan National Institutes of Health, 84% of patients would see participating successful a objective proceedings if suggested by their physician, but only 3% to 5% of eligible big crab patients really enroll. The Trial Finder intends to thief adjacent that gap.
Patients statesman by selecting their information and ZIP code. The Trial Finder past guides them done circumstantial questions astir illness stage, anterior treatment, and different cardinal factors, returning a tailored database of tests for which they whitethorn beryllium eligible. Each consequence includes nan spot of nan lucifer to nan proceedings criteria and nan proceedings tract s region from their location.
Physicians usage nan aforesaid interface to lucifer patients pinch applicable trials, helping place due opportunities quickly and accurately.
Researchers tin hunt thousands of radiopharmaceutical tests worldwide utilizing circumstantial parameters specified arsenic proceedings phase, type of radionuclide, and target. The real-time Quick Charts characteristic provides a elaborate breakdown of proceedings types, locations, sponsors and different criteria.
The Global Radiopharmaceutical Trial Finder is simply a powerful illustration of really AI tin beryllium harnessed to make atomic medicine much accessible to patients. With this tool, patients and their referring providers person life-saving attraction astatine their fingertips. The Global Radiopharmaceutical Trial Finder is disposable astatine www.snmmi.org/TrialFinder.